- Home
- Publications
- Publication Search
- Publication Details
Title
Marine-Derived Pharmaceuticals - Challenges and Opportunities
Authors
Keywords
-
Journal
Biomolecules & Therapeutics
Volume 24, Issue 6, Pages 561-571
Publisher
The Korean Society of Applied Pharmacology
Online
2016-10-31
DOI
10.4062/biomolther.2016.181
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term response to first-line trabectedin in an elderly female patient with a metastatic leiomyosarcoma unfit for anthracycline
- (2016) Marco Maruzzo et al. ANTI-CANCER DRUGS
- Marine Sponges as a Drug Treasure
- (2016) Komal Anjum et al. Biomolecules & Therapeutics
- Marine natural products
- (2016) John W. Blunt et al. NATURAL PRODUCT REPORTS
- An Ocean of Discovery: Biodiversity Beyond the Census of Marine Life
- (2016) Paul Snelgrove PLANTA MEDICA
- Combined LC/UV/MS and NMR Strategies for the Dereplication of Marine Natural Products
- (2016) Ignacio Pérez-Victoria et al. PLANTA MEDICA
- Drugs and Drug Candidates from Marine Sources: An Assessment of the Current “State of Play”
- (2016) David Newman et al. PLANTA MEDICA
- Marine natural products with anti-inflammatory activity
- (2015) Randy Chi Fai Cheung et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Identification and analysis of the bacterial endosymbiont specialized for production of the chemotherapeutic natural product ET-743
- (2015) Michael M. Schofield et al. ENVIRONMENTAL MICROBIOLOGY
- Caldora penicillatagen. nov., comb. nov. (Cyanobacteria), a pantropical marine species with biomedical relevance
- (2015) Niclas Engene et al. JOURNAL OF PHYCOLOGY
- Statistical Research on the Bioactivity of New Marine Natural Products Discovered during the 28 Years from 1985 to 2012
- (2015) Yiwen Hu et al. Marine Drugs
- Marine-Based Nutraceuticals: An Innovative Trend in the Food and Supplement Industries
- (2015) Hafiz Suleria et al. Marine Drugs
- Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
- (2014) M D’Incalci et al. BRITISH JOURNAL OF CANCER
- Marine-Sourced Anti-Cancer and Cancer Pain Control Agents in Clinical and Late Preclinical Development
- (2014) David Newman et al. Marine Drugs
- Co-Cultivation—A Powerful Emerging Tool for Enhancing the Chemical Diversity of Microorganisms
- (2014) Andreas Marmann et al. Marine Drugs
- Marketed Marine Natural Products in the Pharmaceutical and Cosmeceutical Industries: Tips for Success
- (2014) Ana Martins et al. Marine Drugs
- Molecular and Cellular Mechanism of Okadaic Acid (OKA)-Induced Neurotoxicity: A Novel Tool for Alzheimer’s Disease Therapeutic Application
- (2014) Pradip K. Kamat et al. MOLECULAR NEUROBIOLOGY
- Exploring Marine Resources for Bioactive Compounds
- (2014) Paula Kiuru et al. PLANTA MEDICA
- Tetrodotoxin: Chemistry, Toxicity, Source, Distribution and Detection
- (2014) Vaishali Bane et al. Toxins
- Sense and nonsense of high-dose cytarabine for acute myeloid leukemia
- (2013) B. Lowenberg BLOOD
- Long-Chain Omega-3 Fatty Acids Improve Brain Function and Structure in Older Adults
- (2013) A. Veronica Witte et al. CEREBRAL CORTEX
- Brentuximab Vedotin: A Review of Its Use in Patients with Hodgkin Lymphoma and Systemic Anaplastic Large Cell Lymphoma Following Previous Treatment Failure
- (2013) Karly P. Garnock-Jones DRUGS
- Microbial natural products: molecular blueprints for antitumor drugs
- (2013) Lesley-Ann Giddings et al. JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
- Beneficial Effects of Marine Algal Compounds in Cosmeceuticals
- (2013) Noel Thomas et al. Marine Drugs
- A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin
- (2012) Federica Grosso et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The European Medicines Agency Review of Eribulin for the Treatment of Patients with Locally Advanced or Metastatic Breast Cancer: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use
- (2012) E. Pean et al. CLINICAL CANCER RESEARCH
- Brentuximab Vedotin
- (2012) C. Deng et al. CLINICAL CANCER RESEARCH
- Clinical Binding Properties, Internalization Kinetics, and Clinicopathologic Activity of Brentuximab Vedotin: An Antibody-Drug Conjugate for CD30-Positive Lymphoid Neoplasms
- (2012) Jonathan R. Fromm et al. Clinical Lymphoma Myeloma & Leukemia
- New and emerging analytical techniques for marine biotechnology
- (2012) J Grant Burgess CURRENT OPINION IN BIOTECHNOLOGY
- Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study
- (2012) Barbara Pro et al. JOURNAL OF CLINICAL ONCOLOGY
- Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
- (2012) Anas Younes et al. JOURNAL OF CLINICAL ONCOLOGY
- Bioprospecting of Marine Invertebrates for New Natural Products — A Chemical and Zoogeographical Perspective
- (2012) Miguel Costa Leal et al. MOLECULES
- Marine Protistan Diversity
- (2011) David A. Caron et al. Annual Review of Marine Science
- Highlights of marine invertebrate-derived biosynthetic products: Their biomedical potential and possible production by microbial associants
- (2011) Ocky K. Radjasa et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Statistical Research on Marine Natural Products Based on Data Obtained between 1985 and 2008
- (2011) Gu-Ping Hu et al. Marine Drugs
- Advances in therapy: eribulin improves survival for metastatic breast cancer
- (2010) Patrick G. Morris ANTI-CANCER DRUGS
- Pharmaceuticals from marine natural products: surge or ebb?
- (2010) Russell T Hill et al. CURRENT OPINION IN BIOTECHNOLOGY
- Brentuximab vedotin: delivering an antimitotic drug to activated lymphoma cells
- (2010) Stephen M Ansell EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Antiviral Lead Compounds from Marine Sponges
- (2010) Sunil Sagar et al. Marine Drugs
- Bioactive natural products from marine sponges and fungal endophytes
- (2010) Peter Proksch et al. PHYTOCHEMISTRY REVIEWS
- The odyssey of marine pharmaceuticals: a current pipeline perspective
- (2010) Alejandro M.S. Mayer et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Bioactive Compounds from Marine Bacteria and Fungi
- (2010) Abdessamad Debbab et al. Microbial Biotechnology
- Discovery of Green Fluorescent Protein (GFP) (Nobel Lecture)
- (2009) Osamu Shimomura ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Eribulin Binds at Microtubule Ends to a Single Site on Tubulin To Suppress Dynamic Instability
- (2009) Jennifer A. Smith et al. BIOCHEMISTRY
- Development of Yondelis® (trabectedin, ET-743). A semisynthetic process solves the supply problem
- (2009) Carmen Cuevas et al. NATURAL PRODUCT REPORTS
- Green fluorescent proteins are light-induced electron donors
- (2009) Alexey M Bogdanov et al. Nature Chemical Biology
- Palytoxin: Membrane mechanisms of action
- (2009) Chau H. Wu TOXICON
- Discovery and development of the anticancer agent salinosporamide A (NPI-0052)
- (2008) William Fenical et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Deep-sea natural products
- (2008) Danielle Skropeta NATURAL PRODUCT REPORTS
- Drug development from marine natural products
- (2008) Tadeusz F. Molinski et al. NATURE REVIEWS DRUG DISCOVERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started